Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 84


Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010-2013.

Diomandé FV, Yaméogo TM, Vannice KS, Preziosi MP, Viviani S, Ouandaogo CR, Keita M, Djingarey MH, Mbakuliyemo N, Akanmori BD, Sow SO, Zuber PL.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S459-66. doi: 10.1093/cid/civ599.


Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.

Dellepiane N, Akanmori BD, Gairola S, Jadhav SS, Parker C, Rodriguez C, Srivastava S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S428-33. doi: 10.1093/cid/civ491.


Polio eradication in the African Region on course despite public health emergencies.

Okeibunor JC, Ota MC, Akanmori BD, Gumede N, Shaba K, Kouadio KI, Poy A, Mihigo R, Salla M, Moeti MR.

Vaccine. 2015 Aug 21. pii: S0264-410X(15)01146-9. doi: 10.1016/j.vaccine.2015.08.024. [Epub ahead of print]


Age-related pattern and monocyte-acquired haemozoin associated production of erythropoietin in children with severe malarial anaemia in Ghana.

Abugri J, Tetteh JK, Oseni LA, Mensah-Brown HE, Delimini RK, Obuobi DO, Akanmori BD.

BMC Res Notes. 2014 Aug 20;7:551. doi: 10.1186/1756-0500-7-551.


Prevalence of peripheral blood parasitaemia, anaemia and low birthweight among pregnant women in a suburban area in coastal Ghana.

Stephens JK, Ofori MF, Quakyi IA, Wilson ML, Akanmori BD.

Pan Afr Med J. 2014 Jan 18;17 Suppl 1:3. doi: 10.11694/pamj.supp.2014.17.1.3541. eCollection 2014.


High plasma levels of soluble intercellular adhesion molecule (ICAM)-1 are associated with cerebral malaria.

Adukpo S, Kusi KA, Ofori MF, Tetteh JK, Amoako-Sakyi D, Goka BQ, Adjei GO, Edoh DA, Akanmori BD, Gyan BA, Dodoo D.

PLoS One. 2013 Dec 27;8(12):e84181. doi: 10.1371/journal.pone.0084181. eCollection 2013.


Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region.

Okeibunor JC, Akanmori BD, Balcha GM, Mihigo R, Vaz RM, Nshimirimana D.

Vaccine. 2013 Aug 20;31(37):3772-6. doi: 10.1016/j.vaccine.2013.06.038. Epub 2013 Jun 22.


MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines.

Vannice KS, Brown GV, Akanmori BD, Moorthy VS.

Malar J. 2012 Nov 9;11:372. doi: 10.1186/1475-2875-11-372.


Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia.

Boeuf PS, Loizon S, Awandare GA, Tetteh JK, Addae MM, Adjei GO, Goka B, Kurtzhals JA, Puijalon O, Hviid L, Akanmori BD, Behr C.

Malar J. 2012 Aug 1;11:253. doi: 10.1186/1475-2875-11-253.


Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study.

Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K.

Malar J. 2012 May 17;11:168. doi: 10.1186/1475-2875-11-168.


The rs150311303 polymorphism in FcγRIIa enhances IgG binding capacity.

Omar AH, Shibata H, Yasunami M, Yamazaki A, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K.

Scand J Immunol. 2012 Aug;76(2):167-74. doi: 10.1111/j.1365-3083.2012.02715.x.


Human leukocyte antigen class I polymorphisms influence the mild clinical manifestation of Plasmodium falciparum infection in Ghanaian children.

Yamazaki A, Yasunami M, Ofori M, Horie H, Kikuchi M, Helegbe G, Takaki A, Ishii K, Omar AH, Akanmori BD, Hirayama K.

Hum Immunol. 2011 Oct;72(10):881-8. doi: 10.1016/j.humimm.2011.06.007. Epub 2011 Jul 1.


Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.

Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, Ocran J, Adu-Amankwah S, Geneshan H, Abot E, Legano J, Banania G, Sayo R, Brambilla D, Kumar S, Doolan DL, Rogers WO, Epstein J, Richie TL, Sedegah M.

Malar J. 2011 Jun 20;10:168. doi: 10.1186/1475-2875-10-168.


Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries.

Kisser A, Heininger U, Moorthy VS, Akanmori BD, Leroy O.

Vaccine. 2011 May 31;29(24):4173-4. doi: 10.1016/j.vaccine.2011.03.008. Epub 2011 Apr 5. No abstract available.


MALVAC 2009: progress and challenges in development of whole organism malaria vaccines for endemic countries, 3-4 June 2009, Dakar, Senegal.

Pinder M, Moorthy VS, Akanmori BD, Genton B, Brown GV.

Vaccine. 2010 Jul 5;28(30):4695-702. doi: 10.1016/j.vaccine.2010.04.091. Epub 2010 May 14.


Joint reviews and inspections: strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa.

Maïga D, Akanmori BD, Chocarro L.

Vaccine. 2009 Dec 11;28(2):571-5. doi: 10.1016/j.vaccine.2009.09.117. Epub 2009 Oct 13. Review.


Regulatory oversight of clinical trials in Africa: progress over the past 5 years.

Maïga D, Akanmori BD, Chocarro L.

Vaccine. 2009 Dec 9;27(52):7249-52. doi: 10.1016/j.vaccine.2009.08.113. Epub 2009 Sep 11.


Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.

Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Theisen M.

Malar J. 2008 Jul 29;7:142. doi: 10.1186/1475-2875-7-142.


Levels of soluble CD163 and severity of malaria in children in Ghana.

Kusi KA, Gyan BA, Goka BQ, Dodoo D, Obeng-Adjei G, Troye-Blomberg M, Akanmori BD, Adjimani JP.

Clin Vaccine Immunol. 2008 Sep;15(9):1456-60. doi: 10.1128/CVI.00506-07. Epub 2008 Jul 16.


Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania.

Vestergaard LS, Lusingu JP, Nielsen MA, Mmbando BP, Dodoo D, Akanmori BD, Alifrangis M, Bygbjerg IC, Lemnge MM, Staalsoe T, Hviid L, Theander TG.

Infect Immun. 2008 Jun;76(6):2706-14. doi: 10.1128/IAI.01401-06. Epub 2008 Feb 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk